Theragnostics, An Issue of PET Clinics

<ul><li>Contains <b>12 relevant, practice-oriented topics</b> including theragnostics trials; neuroendocrine tumors: diagnostics; prostate-specific membrane antigen: diagnostics; theragnostics: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more.</li><li>Provides in-depth <b>clinical reviews on theragnostics</b>, offering actionable insights for clinical practice.</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.</li></ul>In this issue of <i>PET Clinics</i>, guest editors Drs. Andrei Iagaru and Heather A. Jacene bring their considerable expertise to the topic of <b>Theragnostics</b>. Top experts in the field discuss neuroendocrine tumors: beta-labeled peptides; prostate-specific membrane antigen: interpretation criteria, standardized reporting and the use of artificial intelligence; prostate cancer (gastrin-releasing peptide receptor); selective internal radiation therapy; future directions in theragnostics; and more.